Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Novacea Inc.

Division of Paratek Pharmaceuticals Inc.

Latest From Novacea Inc.

Deal Watch: Genentech Pays Big For Seragon’s Early Assets

Genentech pays $725 million upfront for San Diego oncology firm Seragon, and Bluebird adds gene-editing and cell-signaling capabilities by acquiring Precision Genomic Engineering. It was a deal-heavy week ahead of the July 4th Holiday.

BioPharmaceutical Deals

Financings Of The Fortnight: Biotech IPO Trends Continue With Supernus’ Offering – Haircuts, Insider Buys

Plus news on recent financing activity by Argos, Telstar, Castlight Health and Transcept.

BioPharmaceutical Medical Device

New US company formed to develop hypoxia-activated prodrugs

The University of Oregon in the US has spun out a new company, Cascade ProDrug, and given it exclusive ownership of technology that activates certain prodrugs in oxygen-depleted (hypoxic) tissues.

Cancer Companies

Transcept cuts staff after Purdue deal

Transcept Pharmaceuticals is to cut around 30% of its workforce, despite receiving $25 million up front as part of a licensing deal that it signed with Purdue Pharmaceuticals earlier this month.

See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Novacea Pharmaceuticals Inc.
  • D-Novo Therapeutics
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Paratek Pharmaceuticals Inc.
  • Senior Management
  • Edward C Albini, VP, CFO
    Fong Wang Clow, SVP, Dev.
    Edward Schnipper, MD, EVP, CMO
    Amar Singh, Chief Commercialization Officer
    John G Curd, MD, Pres. & CSO
    Karen E Hartwig, VP, Mktg.
  • Contact Info
  • Novacea Inc.
    Phone: (650) 228-1800
    400 Oyster Blvd.
    Ste. 200
    S. San Francisco, CA 94080